nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
ALIGNing the treatment of IgA nephropathy: Reducing proteinuria with endothelin A receptor inhibition
|
Willcocks, Lisa |
|
|
6 |
1 |
p. |
artikel |
2 |
Belzutifan for renal cell carcinoma: Balancing regulatory approval with societal and patient impact
|
Chahoud, Jad |
|
|
6 |
1 |
p. |
artikel |
3 |
Cell-mediated immunotherapy: A new frontier in preventing disease progression and treating drug-resistant cancer
|
Slavin, Shimon |
|
|
6 |
1 |
p. |
artikel |
4 |
Clinical advances of mRNA vaccines for cancer immunotherapy
|
Yaremenko, Alexey V. |
|
|
6 |
1 |
p. |
artikel |
5 |
First-line zorifertinib for EGFR-mutant non-small cell lung cancer with central nervous system metastases: The phase 3 EVEREST trial
|
Zhou, Qing |
|
|
6 |
1 |
p. |
artikel |
6 |
Gut microbiome pattern impacts treatment response in primary biliary cholangitis
|
Liu, Qiaoyan |
|
|
6 |
1 |
p. |
artikel |
7 |
Heterozygous cis HYDIN mutations cause primary ciliary dyskinesia
|
Suryadinata, Randy |
|
|
6 |
1 |
p. |
artikel |
8 |
If it is a solid tumor target, then it may be a hematologic cancer target: Bridging the great divide
|
Adashek, Jacob J. |
|
|
6 |
1 |
p. |
artikel |
9 |
Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes
|
Lu, Jieli |
|
|
6 |
1 |
p. |
artikel |
10 |
Integrating CTLA-4/PD-1 blockade into cervical cancer management: Results of COMPASSION-16
|
How, Jeffrey A. |
|
|
6 |
1 |
p. |
artikel |
11 |
Large-scale pretrained frame generative model enables real-time low-dose DSA imaging: An AI system development and multi-center validation study
|
Zhao, Huangxuan |
|
|
6 |
1 |
p. |
artikel |
12 |
Pembrolizumab plus chemotherapy in frontline treatment of advanced ovarian cancer: Clinical and translational results from a phase 2 trial
|
How, Jeffrey A. |
|
|
6 |
1 |
p. |
artikel |
13 |
Q&A with Lin Shen
|
Shen, Lin |
|
|
6 |
1 |
p. |
artikel |
14 |
Setting “cold” tumors on fire: Cancer therapy with live tumor-targeting bacteria
|
Manole, Simin |
|
|
6 |
1 |
p. |
artikel |
15 |
Tertiary lymphoid structures and cancer immunotherapy: From bench to bedside
|
Peyraud, Florent |
|
|
6 |
1 |
p. |
artikel |
16 |
The climb toward intracranial efficacy: Zorifertinib in EGFR-mutant NSCLC with CNS metastases in the EVEREST trial
|
Roy-O’Reilly, Meaghan |
|
|
6 |
1 |
p. |
artikel |
17 |
The DEBBRAH trial: Trastuzumab deruxtecan in HER2-positive and HER2-low breast cancer patients with leptomeningeal carcinomatosis
|
Vaz Batista, Marta |
|
|
6 |
1 |
p. |
artikel |
18 |
Zinc for GNAO1 encephalopathy: Preclinical profiling and a clinical case
|
Larasati, Yonika A. |
|
|
6 |
1 |
p. |
artikel |